Neurocrine Biosciences market cap
As of November 2026, Neurocrine Biosciences (NBIX) has a market capitalization of $15.85 B, which makes it #844 among the world’s largest public companies. Over the past year its value changed by +2.91%.
Market cap$15.85 B
World rank#844
1 year+2.91%
Share price$156.59
Market cap over time
By year
| Year | Value | Change |
|---|---|---|
| 2026 | $15.85 B | +10.4% |
| 2025 | $14.36 B | +3.90% |
| 2024 | $13.82 B | +3.60% |
| 2023 | $13.34 B | +10.3% |
| 2022 | $12.09 B | +40.2% |
| 2021 | $8.62 B | −11.1% |
| 2020 | $9.70 B | −10.8% |
| 2019 | $10.88 B | +50.5% |
| 2018 | $7.23 B | −7.96% |
| 2017 | $7.85 B | +100% |
| 2016 | $3.92 B | −31.6% |
| 2015 | $5.73 B | +153% |
Market cap history is an estimate: monthly closing price × today’s share count, in US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-20. Not investment advice.